ImCheck Therapeutics
Business Description ImCheck Therapeutics is designing and developing a new generation of immunotherapy antibodies positioned at the crossroads of two high-potential immunological fields: γ9δ2 T cells and a novel super-family of immunomodulators, butyrophilins.
Due to their mechanism of action, and notably their ability to simultaneously modulate innate and adaptive immunity, ImCheck's “first-in-class” activating antibodies may be able to produce superior anti-cancer efficacy as compared to the first-generation of immune checkpoint inhibitors and, when used in combination, overcome the resistance to this class of agents.
Based in Marseille, Provence-Alpes-Cote d'Azur
Tags Biopharma, Biotechnology, Health Care, Life Science, Therapeutics
Website http://www.imchecktherapeutics.com/
Articles about ImCheck Therapeutics:
💡 You're a corporate or investor and looking for startups that are innovating in the same market as
ImCheck Therapeutics? We're happy to assist you with our
Startup Sourcing service.